Literature DB >> 35962936

Modulation of Inflammatory Mediators and Microglial Activation Through Physical Exercise in Alzheimer's and Parkinson's Diseases.

Erin John Rieger de Almeida1, Hélio Jungkenn Ibrahim2, Maria Rosa Chitolina Schetinger3, Cinthia Melazzo de Andrade4, Andréia Machado Cardoso5,6.   

Abstract

Neuroinflammation is an inflammatory process in the central nervous system (CNS), in addition to being one of the main features of Alzheimer's disease (AD) and Parkinson's disease (PD). Microglia are known for their immune functions and have multiple reactive phenotypes related to the types of stages involving neurodegenerative diseases. Depending on the state of activation of microglia in the CNS, it can be neuroprotective or neurotoxic. In this context, AD is a neurodegenerative and neuroinflammatory disease characterized by the deposition of beta-amyloid plaques, formation of fibrillar tangles of tau protein, and loss of neurons due to neurotoxic activation of microglia. However, PD is characterized by the loss of dopaminergic neurons in the substantia nigra and accumulation of alpha-synuclein in the cortical regions, spinal cord, and brain stem, which occurs by microglial activation, contributing to the neuroinflammatory process. In this aspect, the activation of microglia in both pathologies triggers high levels of inflammatory markers, such as interleukins, and causes the neuroinflammatory process of the diseases. Thus, physical exercise is pointed out as neuroprotective, as it can act to strengthen neurogenesis and reduce the inflammatory process. Therefore, the present review addresses the neuroprotective effect of microglia after different types of physical exercise protocols and evaluates the activity and effects of inflammatory and anti-inflammatory parameters and mechanisms of AD and PD. This review will discuss the anti-inflammatory effects of physical exercise through microglia activation with neuroprotective activity and the role of pro-and anti-inflammatory cytokines in AD and PD.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Alzheimer's disease; Anti-inflammatory; Cytokines; Neuroinflammation; Parkinson's disease; Physical exercise

Mesh:

Substances:

Year:  2022        PMID: 35962936     DOI: 10.1007/s11064-022-03713-x

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   4.414


  98 in total

Review 1.  CNS immune privilege: hiding in plain sight.

Authors:  Monica J Carson; Jonathan M Doose; Benoit Melchior; Christoph D Schmid; Corinne C Ploix
Journal:  Immunol Rev       Date:  2006-10       Impact factor: 12.988

Review 2.  Microglia: active sensor and versatile effector cells in the normal and pathologic brain.

Authors:  Uwe-Karsten Hanisch; Helmut Kettenmann
Journal:  Nat Neurosci       Date:  2007-11       Impact factor: 24.884

Review 3.  Pathology of Neurodegenerative Diseases.

Authors:  Brittany N Dugger; Dennis W Dickson
Journal:  Cold Spring Harb Perspect Biol       Date:  2017-07-05       Impact factor: 10.005

Review 4.  Inflammation in CNS neurodegenerative diseases.

Authors:  Jodie Stephenson; Erik Nutma; Paul van der Valk; Sandra Amor
Journal:  Immunology       Date:  2018-04-17       Impact factor: 7.397

Review 5.  Microglia-mediated neuroinflammation in neurodegenerative diseases.

Authors:  Charannya Sozheesvari Subhramanyam; Cheng Wang; Qidong Hu; S Thameem Dheen
Journal:  Semin Cell Dev Biol       Date:  2019-05-11       Impact factor: 7.727

6.  Neuroinflammation Induces Neurodegeneration.

Authors:  D Kempuraj; R Thangavel; P A Natteru; G P Selvakumar; D Saeed; H Zahoor; S Zaheer; S S Iyer; A Zaheer
Journal:  J Neurol Neurosurg Spine       Date:  2016-11-18

Review 7.  Mechanisms underlying inflammation in neurodegeneration.

Authors:  Christopher K Glass; Kaoru Saijo; Beate Winner; Maria Carolina Marchetto; Fred H Gage
Journal:  Cell       Date:  2010-03-19       Impact factor: 41.582

8.  Ellagic Acid Inhibits Neuroinflammation and Cognitive Impairment Induced by Lipopolysaccharides.

Authors:  Guilherme Lopes Dornelles; Juliana Sorraila de Oliveira; Erin John Rieger de Almeida; Camila Benaduce Emanuelli Mello; Bernardo Rodrigues E Rodrigues; Cássia Bagolin da Silva; Letícia Dos Santos Petry; Micheli Mainardi Pillat; Taís Vidal Palma; Cinthia Melazzo de Andrade
Journal:  Neurochem Res       Date:  2020-08-10       Impact factor: 3.996

Review 9.  Activated microglia facilitate the transmission of α-synuclein in Parkinson's disease.

Authors:  Tingting Zheng; Zhengxiang Zhang
Journal:  Neurochem Int       Date:  2021-06-08       Impact factor: 3.921

10.  Functional diversity of microglia - how heterogeneous are they to begin with?

Authors:  Uwe-Karsten Hanisch
Journal:  Front Cell Neurosci       Date:  2013-05-14       Impact factor: 5.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.